Holli H. Dilks (@hollihdilks) 's Twitter Profile
Holli H. Dilks

@hollihdilks

Science and Sports Geek-Go! Fight! Cure!

ID: 455220373

calendar_today04-01-2012 21:34:56

1,1K Tweet

268 Followers

635 Following

Eric Topol (@erictopol) 's Twitter Profile Photo

The time to move to rapid #SARSCoV2 testing is long overdue. It's about switching from diagnosing *infections* to determining whether someone is *infectious* In minutes, not days. Anywhere. Cheap. My table here summarizes the differences and why this should be the #1 US priority

The time to move to rapid #SARSCoV2 testing is long overdue. It's about switching from diagnosing *infections* to  determining whether someone is *infectious*
In minutes, not days. Anywhere. Cheap.
My table here summarizes the differences and why this should be the #1 US priority
Amy Maxmen, PhD (@amymaxmen) 's Twitter Profile Photo

NEW from CDC: #COVID19 outbreak at an overnight camp in Georgia infects *at least* 260 campers & staff. -51% of positives 6-10yo -44% 11-17 yo -Camp required a test <12 days before arriving & attempted "pods" -Masks required for staff but NOT campers (1/2)

Foundation Medicine (@foundationatcg) 's Twitter Profile Photo

“Through this partnership, we have the opportunity to design studies from the patients’ perspective and create rapid learning environments to advance patient care,” said Foundation Medicine’s Brian Alexander (Brian Alexander). Read more: bit.ly/3gZbD6F OneOncology

Maggie Keresteci 🇨🇦 (@maggiekeresteci) 's Twitter Profile Photo

She didn’t fail 6 rounds of chemotherapy. Chemo failed her. She didn’t progress, the disease progressed. She never complained about side effects. She reported them. She didn't become palliative, she needed a new way of treating her whole being as she lived #caregiver #WordsMatter

Vivek Subbiah, MD (@viveksubbiah) 's Twitter Profile Photo

🥁🥁🥁Recent FDA approvals for #NSCLC May 6 - Capmatinib - METex14 May 9 - Selpercatinib - RET-fusion May 18 - Atezolizumab first-line May 15 - Nivo/ipi May 26 - Brigatinib - ALK-fusion And today !!! 👇🏼 Sept 4 - Pralsetinib- RET fusion !!! FDA approved ✅✅✅

Amgen Oncology (@amgenoncology) 's Twitter Profile Photo

KRAS is one of the most common oncogenic mutations in human cancers and scientists have been seeking a way to target it for almost 40 years. Amgen 🧪🔬🧬 is committed to taking on this challenge by investigating #KRASG12C. Learn more at AmgenOncology.com #WorldCancerResearchDay

Eric Topol (@erictopol) 's Twitter Profile Photo

This will go down in history as one of science and medical research's greatest achievements. Perhaps the most impressive. I put together a preliminary timeline of some key milestones to show how several years of work were compressed into months.

This will go down in history as one of science and medical research's greatest achievements. Perhaps the most impressive.
I put together a preliminary timeline of some key milestones to show how several years of work were compressed into months.
Holli H. Dilks (@hollihdilks) 's Twitter Profile Photo

Great explanation of why KRAS has previously been an “undruggable” target. With the advent of small molecule inhibitors, #NGS is crucial to unlock treatment options! #PrecisionMedicine #CGP #targetedtherapy #NSLC

Prof. Shane Crotty (@profshanecrotty) 's Twitter Profile Photo

At this point, you are either vaccinated or you are going to catch Delta. And whether you are young adult or old, when you catch Delta unvaccinated, you will have the highest chance of being hospitalized compared to almost any disease you have caught in your life.

At this point, you are either vaccinated or you are going to catch Delta.
And whether you are young adult or old, when you catch Delta unvaccinated, you will have the highest chance of being hospitalized compared to almost any disease you have caught in your life.
Foundation Medicine (@foundationatcg) 's Twitter Profile Photo

Our data at #ASCO22 showcases our commitment to understanding cancer at the genomic level. Establishing precision medicine as the standard of care in early cancer is the next step in the journey. Learn more from Chief Scientific Officer, Priti Hegde: bit.ly/3MgrWuK

Foundation Medicine (@foundationatcg) 's Twitter Profile Photo

#Announcing the launch of FoundationReport+, a new interactive digital reporting experience to enhance usability, convenience and flexibility of comprehensive genomic profiling (CGP) results for physicians. Learn more: bit.ly/3gavTH8